Pirarubicin

Description

Pirarubicin is a new anthracycline anticancer agent structurally related to doxorubicin. In acute leukemia, non-Hodgkin’s lymphoma, breast and ovariail carcinoma, pirarubicin is reportedly superior to doxorubicin and better tolerated. Its major side-effect appears to be myelosuppression, mainly in the form of leucopenia, which is potentially dose-limiting.

Chemical properties

Red Solid

Originator

Meiji Seika (Japan)

The Uses of Pirarubicin

Structural analog of Doxorubicin. Antineoplastic

The Uses of Pirarubicin

Structural analog of Doxorubicin. Antineoplastic.

What are the applications of Application

Pirarubicin is an anti-neoplastic and inhibitor of Topo II

Definition

ChEBI: (7S,9S)-7-[[(2R,4S,5S,6S)-4-amino-6-methyl-5-[[(2R)-2-oxanyl]oxy]-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione is an anthracycline.

brand name

Pinorubicin; Therarubucin